TransMedics Group, Inc. (TMDX) is a publicly traded company in the Healthcare — Medical - Devices industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs.
Is TransMedics Group, Inc. stock overvalued or undervalued in 2026?
As of October 2, 2026, TransMedics Group, Inc. (TMDX) trades at $82.73 with no positive earnings over the last twelve months, according to Kaplio. No valuation verdict: it has no earnings to calculate a P/E from.
Kaplio overview: TransMedics Group, Inc.
Market cap $3B · 52 weeks $62 – $150 (45 % below the high) · P/E no earnings · 2027 expected P/E 36.2× · Dividend none · Next earnings November 4, 2026 · expected EPS $0.27 · Price as of Oct 2 · accounts published Aug 4.
- Valuation: P/Sales 4.1× (no earnings).
- Balance sheet: Net debt/EBITDA −0.1× (solid).
- Earnings: 4 of 8 (uneven).
What would it be worth at its usual multiples?
No valuation verdict: it has no earnings to calculate a P/E from.
What matters in pharma: 1 of 5 pass
- R&D / Revenue 11.4 %, fails.
- Gross margin 59.9 %, fails.
- FCF / Net Income 70.2 %, fails.
- ROIC 10.9 %, borderline.
- Net debt / EBITDA −0.1×, passes.
Against its peers (reference peers) — TransMedics Group, Inc.: P/E —; EV/EBITDA —; ROIC —; $2.9B. Bruker Corporation (P/E —; EV/EBITDA 46.2×; ROIC 2.6 %; $9.7B), Option Care Health, Inc. (P/E 17.0×; EV/EBITDA 14.9×; ROIC 9.3 %; $3.4B), Indivior Pharmaceuticals Inc (P/E 12.6×; EV/EBITDA 15.3×; ROIC 70.8 %; $4.5B).
Price Performance
| 1 month | -7.77% |
| 3 months | +17.82% |
| Year-to-date | -31.78% |
| 1 year | -27.16% |
| 3 years | +60.12% |
| 5 years | +171.65% |
Related companies: AKRO · BRKR · GKOS · HNGE · IMVT · INDV · KYMR
Explore sector: Healthcare · Medical - Devices
More sections of TMDX: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks